Clinical and Economic Outcomes of Dronedarone Versus Amiodarone Among Patients With Atrial Fibrillation
In this study, lower event/incidence rates of AEs and health care resource use were observed in patients with atrial fibrillation treated with dronedarone versus amiodarone.
Authors
- Divya Shridharmurthy
- Benjamin Adam Steinberg (ORCID: https://orcid.org/0000-0002-4729-7820)
- Samuel Huse (ORCID: https://orcid.org/0009-0001-7633-2293)
- Jagmeet P. Singh (ORCID: https://orcid.org/0000-0002-2724-529X)
- Ron Preblick (ORCID: https://orcid.org/0000-0002-7923-041X)
- Jason Rashkin
- Chris Colby (ORCID: https://orcid.org/0000-0002-1013-880X)
- David S. McKindley (ORCID: https://orcid.org/0000-0002-4402-6814)
- Firas Dabbous (ORCID: https://orcid.org/0000-0003-3713-3045)
Institutions
- Ithaka Harbors (US)
- University of Utah (US)
- Denver Health Medical Center (US)
- Morristown Medical Center (US)
- Massachusetts General Hospital (US)
- C3I (United States) (US)
- University of Colorado Anschutz Medical Campus (US)
- University of Colorado Denver (US)
Publication Details
- Journal
- Journal of the American Heart Association
- Published
- 2025-12-19
- DOI
- https://doi.org/10.1161/jaha.125.042178
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00